GlassScriptPhysician profile
Jimmy D Penn
NPI 1295934735
$2,977.00
in general payments reported to CMS, 2019-2025
11 companies · $1,719 in 2025
The $1,719 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.64 · 2022: $17.51 · 2023: $280 · 2024: $947 · 2025: $1,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,244 · Travel and Lodging: $927 · Consulting Fee: $775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.08 |
| Travel and Lodging | $926.77 |
| Consulting Fee | $775.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,443.80 | 2025 | Minimed 780g |
| Embecta Corp. | $775.00 | 2024 | |
| Sanofi-Aventis U.S. LLC | $225.01 | 2024-2025 | |
| Abbott Laboratories | $175.15 | 2023-2024 | Freestyle Libre 3 |
| Alexion Pharmaceuticals, INC. | $123.65 | 2025 | Strensiq |
| Tolmar, INC. | $75.17 | 2023-2025 | Fensolvi |
| Lilly USA, LLC | $47.53 | 2023 | Lyumjev, Baqsimi |
| Dexcom, INC. | $41.35 | 2021-2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $27.89 | 2024 | |
| Sequel Med Tech, LLC | $24.94 | 2025 | Twiist |
| Xeris Pharmaceuticals, INC. | $17.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jimmy Penn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.